211 related articles for article (PubMed ID: 22019959)
1. Inverse relationship of cannabimimetic (R+)WIN 55, 212 on behavior and seizure threshold during the juvenile period.
Rudenko V; Rafiuddin A; Leheste JR; Friedman LK
Pharmacol Biochem Behav; 2012 Jan; 100(3):474-84. PubMed ID: 22019959
[TBL] [Abstract][Full Text] [Related]
2. WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway.
Fakhfouri G; Ahmadiani A; Rahimian R; Grolla AA; Moradi F; Haeri A
Neuropharmacology; 2012 Sep; 63(4):653-66. PubMed ID: 22634229
[TBL] [Abstract][Full Text] [Related]
3. Activation of the cannabinoid type-1 receptor mediates the anticonvulsant properties of cannabinoids in the hippocampal neuronal culture models of acquired epilepsy and status epilepticus.
Blair RE; Deshpande LS; Sombati S; Falenski KW; Martin BR; DeLorenzo RJ
J Pharmacol Exp Ther; 2006 Jun; 317(3):1072-8. PubMed ID: 16469864
[TBL] [Abstract][Full Text] [Related]
4. WIN 55,212-2 Reverted Pilocarpine-Induced Status Epilepticus Early Changes of the Interaction among 5-HT
Di Maio R; Colangeli R; Di Giovanni G
ACS Chem Neurosci; 2019 Jul; 10(7):3296-3306. PubMed ID: 30912644
[TBL] [Abstract][Full Text] [Related]
5. Perinatal seizures preferentially protect CA1 neurons from seizure-induced damage in prepubescent rats.
Liu H; Friedman LK; Kaur J
Seizure; 2006 Jan; 15(1):1-16. PubMed ID: 16309925
[TBL] [Abstract][Full Text] [Related]
6. Sequel of spontaneous seizures after kainic acid-induced status epilepticus and associated neuropathological changes in the subiculum and entorhinal cortex.
Drexel M; Preidt AP; Sperk G
Neuropharmacology; 2012 Oct; 63(5):806-17. PubMed ID: 22722023
[TBL] [Abstract][Full Text] [Related]
7. Prolonged exposure to WIN55,212-2 causes downregulation of the CB1 receptor and the development of tolerance to its anticonvulsant effects in the hippocampal neuronal culture model of acquired epilepsy.
Blair RE; Deshpande LS; Sombati S; Elphick MR; Martin BR; DeLorenzo RJ
Neuropharmacology; 2009 Sep; 57(3):208-18. PubMed ID: 19540252
[TBL] [Abstract][Full Text] [Related]
8. Involvement of spinal cannabinoid receptors in the antipruritic effects of WIN 55,212-2, a cannabinoid receptor agonist.
Bilir KA; Anli G; Ozkan E; Gunduz O; Ulugol A
Clin Exp Dermatol; 2018 Jul; 43(5):553-558. PubMed ID: 29424035
[TBL] [Abstract][Full Text] [Related]
9. Post-status epilepticus treatment with the cannabinoid agonist WIN 55,212-2 prevents chronic epileptic hippocampal damage in rats.
Di Maio R; Cannon JR; Greenamyre JT
Neurobiol Dis; 2015 Jan; 73():356-65. PubMed ID: 25447228
[TBL] [Abstract][Full Text] [Related]
10. Retigabine calms seizure-induced behavior following status epilepticus.
Slomko AM; Naseer Z; Ali SS; Wongvravit JP; Friedman LK
Epilepsy Behav; 2014 Aug; 37():123-32. PubMed ID: 25016241
[TBL] [Abstract][Full Text] [Related]
11. Effects of cannabinoids and endocannabinoid hydrolysis inhibition on pentylenetetrazole-induced seizure and electroencephalographic activity in rats.
Vilela LR; Medeiros DC; Rezende GH; de Oliveira AC; Moraes MF; Moreira FA
Epilepsy Res; 2013 May; 104(3):195-202. PubMed ID: 23352737
[TBL] [Abstract][Full Text] [Related]
12. Development of pharmacoresistance to benzodiazepines but not cannabinoids in the hippocampal neuronal culture model of status epilepticus.
Deshpande LS; Blair RE; Nagarkatti N; Sombati S; Martin BR; DeLorenzo RJ
Exp Neurol; 2007 Apr; 204(2):705-13. PubMed ID: 17289026
[TBL] [Abstract][Full Text] [Related]
13. Effects of WIN 55,212-2 mesylate on the anticonvulsant action of lamotrigine, oxcarbazepine, pregabalin and topiramate against maximal electroshock-induced seizures in mice.
Luszczki JJ; Wlaz A; Karwan S; Florek-Luszczki M; Czuczwar SJ
Eur J Pharmacol; 2013 Nov; 720(1-3):247-54. PubMed ID: 24161913
[TBL] [Abstract][Full Text] [Related]
14. Resistance of immature hippocampus to morphologic and physiologic alterations following status epilepticus or kindling.
Haas KZ; Sperber EF; Opanashuk LA; Stanton PK; Moshé SL
Hippocampus; 2001; 11(6):615-25. PubMed ID: 11811655
[TBL] [Abstract][Full Text] [Related]
15. Synergistic action of CB
Colangeli R; Di Maio R; Pierucci M; Deidda G; Casarrubea M; Di Giovanni G
Neurobiol Dis; 2019 May; 125():135-145. PubMed ID: 30716469
[TBL] [Abstract][Full Text] [Related]
16. Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats.
Spano MS; Fattore L; Cadeddu F; Fratta W; Fadda P
Psychopharmacology (Berl); 2013 Feb; 225(3):531-42. PubMed ID: 22903392
[TBL] [Abstract][Full Text] [Related]
17. Methamphetamine neurotoxicity increases brain expression and alters behavioral functions of CB₁ cannabinoid receptors.
Bortolato M; Frau R; Bini V; Luesu W; Loriga R; Collu M; Gessa GL; Ennas MG; Castelli MP
J Psychiatr Res; 2010 Oct; 44(14):944-55. PubMed ID: 20378129
[TBL] [Abstract][Full Text] [Related]
18. Anticonvulsant and Neuroprotective Effects of Cannabidiol During the Juvenile Period.
Friedman LK; Wongvravit JP
J Neuropathol Exp Neurol; 2018 Oct; 77(10):904-919. PubMed ID: 30169677
[TBL] [Abstract][Full Text] [Related]
19. Antinociceptive effect of intrathecal cannabinoid receptor agonist WIN 55,212-2 in a rat bone tumor pain model.
Cui JH; Kim WM; Lee HG; Kim YO; Kim CM; Yoon MH
Neurosci Lett; 2011 Apr; 493(3):67-71. PubMed ID: 21195743
[TBL] [Abstract][Full Text] [Related]
20. Topical WIN55212-2 alleviates intraocular hypertension in rats through a CB1 receptor mediated mechanism of action.
Oltmanns MH; Samudre SS; Castillo IG; Hosseini A; Lichtman AH; Allen RC; Lattanzio FA; Williams PB
J Ocul Pharmacol Ther; 2008 Feb; 24(1):104-15. PubMed ID: 18201139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
